KR950703973A - Use of INOSITOLTRISPHOSPHATE for Drug Preparation - Google Patents

Use of INOSITOLTRISPHOSPHATE for Drug Preparation

Info

Publication number
KR950703973A
KR950703973A KR1019950701801A KR19950701801A KR950703973A KR 950703973 A KR950703973 A KR 950703973A KR 1019950701801 A KR1019950701801 A KR 1019950701801A KR 19950701801 A KR19950701801 A KR 19950701801A KR 950703973 A KR950703973 A KR 950703973A
Authority
KR
South Korea
Prior art keywords
inositol
trisphosphate
salt
drug preparation
inositoltrisphosphate
Prior art date
Application number
KR1019950701801A
Other languages
Korean (ko)
Inventor
시렌 마티
Original Assignee
잉그브 스텐베르그
페르스토르프 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 잉그브 스텐베르그, 페르스토르프 에이비 filed Critical 잉그브 스텐베르그
Publication of KR950703973A publication Critical patent/KR950703973A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Abstract

이 발명은 진통제로서 효력있는 약물제조용 이노시톨-트리스포스페이트의 사용에 관한 것이다.This invention relates to the use of inositol-trisphosphate for the production of potent drugs as analgesics.

Description

약물 조제용 이노시톨 트리스포스페이트(INOSITOLTRISPHOSPHATE)의 사용Use of INOSITOLTRISPHOSPHATE for Drug Preparation

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (6)

진통제의 효력이 있는 것을 특징으로 하는 약물조제용 이노시톨 트리스포스페이트(IP3)의 적어도 1개의 이성체의 사용.Use of at least one isomer of inositol trisphosphate (IP 3 ) for drug preparation, which is effective in analgesics. 아픔을 방지 또는 완화하고, 아픔에 투항하는 것을 특징으로 하는 이노시톨 트리스포 스페이트(IP3)의 적어도 1개의 이성체의 사용.Use of at least one isomer of inositol trisphosphate (IP 3 ) characterized by preventing or alleviating pain and surrendering to pain. 제1∼2항 중 어느 1개항에 있어서 이노시롤 프리스포스페이트의 상기 이상체는 염형태로 있는 것을 특징으로 하는 이노시톨 트리스포스페이트의 사용.Use of inositol trisphosphate according to any one of claims 1 to 2, characterized in that said ideal body of inosyrol prephosphate is in salt form. 제3항에 있어서, 상기 이노시롤 트리스포스페이트 염은, 나트륨, 칼륨, 칼슘 또는 아연의 염인 것을 특징으로 하는 이노시톨 트리스포스페이트의 사용.4. The use of inositol trisphosphate according to claim 3, wherein the inosyl trisphosphate salt is a salt of sodium, potassium, calcium or zinc. 제1∼4항 중 어느 1개항에 있어서, 약물은 정제, 낟알 및 용액으로 구성된 단위 투약형으로 된 것을 특징으로 하는 이노시톨 트리스포스페이트의 사용.5. Use of inositol trisphosphate according to any one of claims 1 to 4, wherein the drug is in unit dosage form consisting of tablets, grains and solutions. 제1∼5항 중 어느 1개항에 있어서, 상기 이노시톨 트리스포스페이트는 디, 미오, 이노시톨-1, 2, 6-트리스포스페이트인 것을 특징으로 하는 이노시톨 트리스포스페이트의 사용.The use of inositol triphosphate according to any one of claims 1 to 5, wherein the inositol triphosphate is di, myo, inositol-1, 2, 6-trisphosphate. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019950701801A 1992-11-05 1993-10-26 Use of INOSITOLTRISPHOSPHATE for Drug Preparation KR950703973A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9203296A SE470511B (en) 1992-11-05 1992-11-05 Use of inositol travel phosphate for drug preparation
SE9203296-0 1992-11-05
PCT/SE1993/000872 WO1994009790A1 (en) 1992-11-05 1993-10-26 The use of inositoltrisphosphate for the preparation of medicaments

Publications (1)

Publication Number Publication Date
KR950703973A true KR950703973A (en) 1995-11-17

Family

ID=20387710

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950701801A KR950703973A (en) 1992-11-05 1993-10-26 Use of INOSITOLTRISPHOSPHATE for Drug Preparation

Country Status (6)

Country Link
EP (1) EP0666748A1 (en)
JP (1) JPH08503454A (en)
KR (1) KR950703973A (en)
AU (1) AU5435994A (en)
SE (1) SE470511B (en)
WO (1) WO1994009790A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9602463D0 (en) * 1996-06-24 1996-06-24 Perstorp Ab The use of growth factor modulating compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515722A (en) * 1982-03-30 1985-05-07 Merck & Co., Inc. Phosphatidyl inositol analogs useful as anti-inflammatory/analgesic agents

Also Published As

Publication number Publication date
SE9203296L (en) 1994-05-06
JPH08503454A (en) 1996-04-16
SE9203296D0 (en) 1992-11-05
WO1994009790A1 (en) 1994-05-11
AU5435994A (en) 1994-05-24
EP0666748A1 (en) 1995-08-16
SE470511B (en) 1994-06-27

Similar Documents

Publication Publication Date Title
ES2170865T3 (en) PHARMACO COMPOSITION TO RELIEF PAIN.
ES2150489T3 (en) 1-AMIDINOFENIL-PIRROLIDONAS, -PIPERIDINONAS, -AZETINONAS AS INHIBITORS OF THE AGGREGATION OF PLATELETS.
ES2017837A6 (en) 4H-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
EP0508488A3 (en) Use of inositol triphosphate for the treatment of diseases associated with metal intoxications
DE69413237D1 (en) Plättchenaggregationsinhibitoren
DE69404116T2 (en) Pharmaceutical dosage unit coated with sugar
CA2270955A1 (en) Pharmaceutical composition containing morphinan derivative for treating drug dependence
MD1560G2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses
CA2140927A1 (en) Platelet aggregation inhibitors
WO1996023771A3 (en) Platelet aggregation inhibitors
KR950703973A (en) Use of INOSITOLTRISPHOSPHATE for Drug Preparation
KR920019365A (en) Pharmaceutical Formulations Containing Dirithromycin
KR950700067A (en) For the treatment of pain and edema of 3,5-diamino-6- (2,3-dichlorophenyl) -1,2,4-triazine (USE OF 3,5-DIAMINO-6- (2,3-DICHLOROPHENYL ) -1,2,4-TRIAZINE FOR THE TREATMENT OF PAIN AND OEDEMA)
SE9403137D0 (en) Derivatives of carbohydrates and compositions containing them
KR920703067A (en) L-α-glycerophoryl-D-myo-inositol for the treatment of peripheral neurological and brain diseases
KR930007451A (en) Arthritis treatment containing uridine as an active ingredient
SE8602060L (en) PHARMACEUTICAL COMPOSITIONS CONTAINING REDUCED GLUTATION
KR910002440A (en) Antifungal treatment of the lens
JPS554397A (en) Novel n11benzoylln22phenyll1*33diaminopropane 22ol*its manufacture and medicine containing it for therapy of acute and chronic gastritis
KR950007852A (en) Arthritis treatment containing uracil as an active ingredient
KR950016756A (en) Fatigue Recovery Composition
KR940003909A (en) (S) -2,3-dihydropolyprenol, (S) -2,3-dihydro polyprenyl monophosphate, methods for their preparation, and agents for inhibiting the growth or metastasis of cancer comprising the same
KR890001543A (en) Diabetes treatment
ES2184285T3 (en) PHARMACEUTICAL COMPOUNDS CONTAINING CINCONINE DICHLORHYDRATE.
Anderson An approach to the study of multiple toxicity

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application